Midjourney Medical Scanner: What 60-Second Ultrasonic CT Means for Longevity Clinics

Midjourney Medical is the most unusual longevity-diagnostics story of June 2026: a company known for AI image generation is now building a water-based, full-body ultrasound tomography scanner that it says could scan a person in about 60 seconds.

The cleaner technical description is full-body ultrasound tomography: “ultrasonic CT” captures the idea of reconstruction from many angles, but it is not conventional x-ray CT.

The announcement matters for longevity clinics because it points toward a future where body imaging becomes faster, cheaper, and more repeatable. It also exposes the hardest problem in preventive medicine: more data is not the same as better care.

Midjourney describes a shallow-pool experience where a person descends through a ring of underwater sensors. Those sensors send ultrasonic waves through the body from multiple angles, then a compute system reconstructs a 3D map. The company says the goal is a scan that takes no more than 60 seconds and starts with detailed body-composition maps before pursuing FDA-cleared diagnostic capabilities.¹

Butterfly Network, the ultrasound company behind Butterfly iQ, confirmed that the current prototype incorporates 40 Butterfly Ultrasound-on-Chip imaging modules under a co-development and licensing relationship. Butterfly also framed the platform as a full-body tomographic imaging machine, not as a finished diagnostic service already ready for ordinary clinical use.²

That is the useful starting point. The Midjourney scanner is not “AI medicine” in the simple marketing sense. It is ultrasound hardware, reconstruction software, segmentation, workflow design, and a proposed consumer spa model colliding with the regulatory, clinical, and privacy realities of medical imaging.

This article is informational, not medical advice.

Quick answer: what should longevity clinics take from this?

The serious version of the Midjourney Medical scanner story is not “MRI is dead.” It is that repeat imaging may become common enough that clinics need a better operating model for longitudinal body data.

For a longevity clinic, the buyer question is:

If you could scan people frequently, what would you actually do with the data?

A good answer is not “show a beautiful 3D body map.” It is a documented pathway:

• which outputs are wellness metrics versus medical findings;
• who reviews each scan;
• what changes trigger physician review;
• what findings require radiology, primary care, cardiology, oncology, endocrinology, orthopedics, or another specialist;
• how repeat scans are compared without overreacting to noise;
• how the clinic protects sensitive anatomical and health data.

That standard is the same one WLC applies across AI diagnostics in longevity clinics, full-body MRI screening, and DEXA-based body composition. The technology can be exciting. The clinical workflow has to be boring in the right ways.

What Midjourney actually announced

Midjourney announced Midjourney Medical and the Midjourney Scanner as a new hardware direction. The core concept is a water-immersion scan: step into a shallow pool, descend through a sensor ring, and let the system send ultrasonic waves through the body from many angles.¹

The company describes the sensor ring as hundreds of thousands of tiny elements that can transmit and receive ultrasonic waves. It says the reconstruction task is to turn changes in wave shape, caused by differences in tissue density and stiffness, into a detailed body map. Midjourney also shows raw reconstructions and AI segmentation examples on its announcement page.

The product vision has three layers:

1. Scanner: a full-body ultrasound tomography system with a target scan time of about 60 seconds.
2. Spa: a consumer setting with hot tubs, saunas, cold plunges, and scan rooms, with the first San Francisco spa planned for 2027.
3. Regulatory roadmap: an initial body-composition-map use case, followed by FDA submissions for increased capabilities.

The last point is crucial. Midjourney itself says diagnostic medical capability normally needs FDA approval and that the starting point is body-composition maps.¹ That is not a small caveat. It defines how longevity clinics should talk about the scanner today.

What Butterfly Network confirms

Butterfly’s June 18, 2026 commentary gives the story a more concrete hardware base. The company says the current Midjourney scanner prototype uses 40 Butterfly Ultrasound-on-Chip imaging modules per system under a licensing and co-development agreement.²

Butterfly also says future generations are expected to use substantially more modules. It describes the collaboration through Butterfly Embedded, its licensing and co-development business, and points investors to a prior Form 8-K that disclosed expected payments to Butterfly over a five-year term.

For clinic buyers, this matters because it separates two things that often get blended in headlines:

Layer	What appears current	What remains unproven for longevity clinics
Ultrasound hardware	Butterfly confirms 40 Ultrasound-on-Chip modules in the current prototype	Whether future hardware can scan large populations reliably and reproducibly
Reconstruction and segmentation	Midjourney shows reconstructed body slices and AI segmentation examples	Whether outputs are accurate enough for specific clinical decisions
Body composition	Midjourney says this is the first roadmap use case	Whether it outperforms or replaces DEXA, MRI, or CT for any specific body-composition endpoint
Diagnosis	Midjourney says diagnostic capabilities require FDA approval	Which exact indications, if any, receive clearance or approval
Spa workflow	Midjourney plans a consumer spa setting	Who owns interpretation, follow-up, referrals, consent, and privacy

This is why longevity clinics should track the scanner, but not build medical claims around it yet.

Ultrasound tomography is not MRI, and it is not CT

The phrase “ultrasonic CT” can confuse buyers. In ordinary medical language, CT usually means computed tomography using X-rays. The CDC describes CT scans as imaging tests that use ionizing radiation to create cross-sectional images from different angles.³

Midjourney’s system is different. It is ultrasound tomography: sound waves are sent through the body from many angles and reconstructed computationally. FDA’s ultrasound imaging overview explains that ultrasound uses high-frequency sound waves and does not involve ionizing radiation exposure.⁴

MRI is different again. MRI uses powerful magnetic fields, radiofrequency energy, changing magnetic fields, and computer processing to create detailed images, without X-rays or ionizing radiation.⁵

So the clean distinction is:

Modality	Core physics	Common strength	Main buyer caveat
Ultrasound	Sound waves	Real-time imaging, soft tissue, blood flow, portability, no ionizing radiation	Operator, anatomy, acoustic windows, validation, and interpretation matter
Ultrasound tomography	Sound waves from many angles plus reconstruction	Potential repeatable 3D body maps and body composition	Still needs clinical validation for specific uses
MRI	Magnetic fields and radiofrequency pulses	High soft-tissue contrast, brain/spine/joint/organ detail, no ionizing radiation	Cost, time, access, contraindications, incidental findings
CT	X-rays reconstructed into slices	Fast detail for many urgent, lung, bone, vascular, and cancer contexts	Ionizing radiation and indication discipline

The Midjourney scanner may eventually create a useful new imaging category. But a longevity clinic should not tell patients it replaces MRI, CT, colonoscopy, mammography, coronary imaging, DEXA, radiology interpretation, or guideline-based screening.

The first real use case may be body composition

The body-composition angle is more plausible than broad diagnostic screening as a first clinical-adjacent use case. Midjourney says it plans to start with body-composition maps.¹ That fits a longevity-clinic problem that already exists: buyers want to know whether fat mass, lean mass, muscle distribution, and visceral-risk signals are changing over time.

Today, many clinics use DEXA scans for bone density and body composition. DEXA is not perfect, but it is established, quick, relatively inexpensive, and interpretable when used correctly. Other clinics use MRI or CT for more detailed tissue compartments, often in research or selected medical contexts.

An ultrasound tomography scanner could become interesting if it gives clinics a repeatable, low-friction way to track:

• lean mass by region;
• fat distribution;
• organ or tissue volume trends;
• training response;
• muscle preservation during GLP-1 or weight-loss programs;
• recovery after injury or surgery;
• whether a change is large enough to alter the plan.

But the phrase “track” is doing a lot of work. To be useful, a clinic would need repeatability data, measurement error, reference ranges, comparison protocols, and a clinician who knows when not to act. A dashboard that changes every month is not automatically evidence of improvement or decline.

The better question is not whether a scan looks futuristic. It is whether the clinic can say: “This result changed your training, nutrition, medication review, referral, or follow-up interval.”

The false-positive problem does not disappear because the scan is fast

Ultrasound has no ionizing radiation exposure, which is a meaningful advantage over X-ray CT for repeated use. FDA still recommends prudent use of ultrasound, because ultrasound energy can have biological effects and imaging should be used with a purpose.⁴

The larger risk in a consumer longevity setting may be downstream interpretation.

Whole-body screening has a predictable pattern: the more you look, the more you find. A systematic review of whole-body MRI in asymptomatic adults found a substantial burden of incidental and indeterminate findings, including false-positive findings in studies that reported them.⁶ The exact rates will not transfer directly from MRI to ultrasound tomography, but the governance problem does transfer.

The scale is worth naming: in that MRI review, pooled critical or indeterminate incidental findings were 32.1%, while the pooled false-positive proportion was 16.0% in the studies that reported false positives.⁶ Those figures are an analogy, not a Midjourney-specific estimate.

If frequent scanning becomes easy, clinics need policies for:

• ambiguous structural findings;
• benign lesions that still require confirmation;
• abnormal-but-not-actionable changes;
• repeat-scan noise;
• patient anxiety;
• specialist referral capacity;
• cost of downstream imaging and procedures;
• responsibility when a patient ignores or cannot access follow-up.

This is why our full-body MRI false-positives guide is relevant even though Midjourney is not selling MRI. The modality changes. The screening-harm tradeoff remains.

FDA status: wellness maps are not diagnostic clearance

The regulatory boundary is the line clinics should hold most firmly.

FDA explains that whether a product is a medical device depends heavily on intended use and indications for use. A product intended to diagnose, cure, mitigate, treat, or prevent disease is likely to be treated differently from a low-risk general wellness product.⁷ FDA’s 2026 general wellness guidance also distinguishes products that encourage a healthy lifestyle from products making disease-related medical claims.⁸

As of June 22, 2026, a clinic should not describe the Midjourney scanner as disease-diagnostic unless it can point to a specific FDA-cleared or approved indication for that exact claim.

Midjourney’s announcement acknowledges this boundary by saying it will start with detailed body-composition maps and submit test results to the FDA for increased capabilities.¹ Butterfly’s investor language also flags regulatory clearance or approval as a risk factor for development and commercialization.²

For longevity clinics, the practical rule is simple:

If the clinic says…	Ask…
”This is a wellness body map”	What exactly is measured, how accurate is it, and who reviews changes?
”This detects disease early”	What FDA-cleared or approved indication supports that claim?
”This is like MRI”	For which anatomy, endpoint, and population was it validated against MRI?
”AI interprets the scan”	Is the AI segmentation exploratory, decision support, or a regulated device function?
”You can scan every week”	What finding would trigger medical review, and what noise will be ignored?

Until specific indications are validated and cleared or approved, clinics should describe this category as emerging imaging infrastructure, not proven diagnostic prevention.

What a good longevity clinic would do with repeat scan data

The best use of repeat imaging is not maximum frequency. It is better decisions over time.

A clinic considering any future Midjourney-style scanner should build a follow-up plan after the assessment before it installs the hardware. The plan should say what gets repeated at 3, 6, and 12 months; what changes are clinically meaningful; and who owns each next step.

For body-composition data, a serious clinic might use repeat scans to adjust:

• resistance training volume and progression;
• protein intake and nutrition strategy;
• weight-loss pace;
• GLP-1 muscle-preservation monitoring;
• bone-health evaluation if paired with DEXA or labs;
• rehabilitation plans;
• cardiometabolic priorities when body composition and biomarkers diverge.

For structural or incidental findings, the standard should be stricter:

• a qualified clinician reviews the report;
• abnormal findings are categorized by urgency;
• patients are told what is known, unknown, and optional;
• referrals are documented;
• follow-up responsibility is assigned;
• the patient’s primary physician can receive the result in a usable format.

That is also why clinics should align this technology with broader longevity clinic standards for diagnostics, AI, and biomarkers rather than treating the scanner as a standalone attraction.

Privacy may become the hidden buyer issue

A full-body imaging archive is not a step count. It is sensitive health data that could reveal anatomy, body composition, pregnancy status, implants, injuries, unexpected lesions, and longitudinal changes.

If a scanner lives inside a spa, app, or consumer membership, buyers should not assume every privacy protection works the same way as a hospital record. HHS notes that health-app developers may need to consider multiple federal laws depending on the data collected and services provided, including HIPAA, the FTC Act, the FTC Health Breach Notification Rule, the FD&C Act, COPPA, and information-blocking rules.⁹

The FTC also updated its Health Breach Notification Rule to cover health apps and similar technologies not covered by HIPAA, including unauthorized disclosures of identifiable health information.¹⁰

Before a longevity clinic uses frequent body scanning, it should be able to answer:

1. Who owns the raw scan data, reconstructed images, segmentations, and reports?
2. Can the patient export the data in a usable format?
3. Can the patient delete data, and what backups or derived models remain?
4. Is data used for AI training, product development, or commercial analytics?
5. Which entities can access the data: clinic, spa operator, device vendor, cloud provider, AI vendor, insurer, employer, or research partner?
6. Is the patient giving medical consent, wellness consent, research consent, or all three?
7. What happens after a breach or unauthorized disclosure?

Privacy is not a footnote here. If the promise is lifetime body mapping, data governance is part of the medical product.

How buyers should compare clinics as this category emerges

If you are comparing diagnostic-heavy programs now, do not rank clinics by who mentions the newest scanner first. Rank them by interpretation and follow-up quality.

Use the WLC comparison tool, rankings, and Find Your Clinic wizard to compare diagnostics in context: physician time, radiology review, body-composition tools, biomarkers, follow-up, referral pathways, privacy posture, and price.

For any clinic offering frequent imaging or body-composition tracking, ask:

• Is the scan wellness-only, diagnostic, research, or mixed?
• What claims are supported by current regulatory clearance or approval?
• Who signs the report?
• What does a normal result not rule out?
• What happens after an indeterminate result?
• How often should the scan be repeated, and why?
• What result would change the plan?
• How does the clinic prevent over-testing and anxiety?
• Can the data integrate with the clinic’s tech stack, EMR, wearables, and biomarker dashboards?

The strongest clinics will be able to answer without turning uncertainty into a sales script.

Bottom line

Midjourney Medical’s scanner is worth watching. It combines water-based ultrasound tomography, Butterfly’s chip-based ultrasound modules, heavy compute, body segmentation, and a consumer spa concept in a way that could make repeat body imaging feel normal.

But the frontier is not the same as clinical proof.

For longevity clinics, the responsible position is optimistic but strict: track the technology, understand the physics, prepare for body-composition use cases, and do not claim diagnostic or lifespan benefits before validation and regulatory status support them.

The buyer standard is straightforward:

Do not pay for more scans unless the clinic can explain what happens after the scan.

That means evidence, interpretation, follow-up ownership, privacy, and restraint. If Midjourney-style imaging eventually helps clinics make better decisions, it will be because the medical workflow matured with the machine. If not, it will become another beautiful dashboard searching for a reason to exist.

Footnotes

1. Midjourney. A New Era of Midjourney, accessed June 22, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵

2. Butterfly Network. Butterfly Network Provides Commentary on Midjourney Medical’s Full Body Ultrasound Scanner Announcement, June 18, 2026; accessed June 22, 2026. ↩ ↩² ↩³

3. Centers for Disease Control and Prevention. Facts About Computed Tomography (CT) Scans, February 15, 2024; accessed June 22, 2026. ↩

4. U.S. Food and Drug Administration. Ultrasound Imaging, accessed June 22, 2026. ↩ ↩²

5. RadiologyInfo.org. MRI Safety, reviewed December 22, 2025; accessed June 22, 2026. ↩

6. O’Connor SD, Pickhardt PJ, Kim DH, et al. Whole-body MRI for preventive health screening. Journal of Magnetic Resonance Imaging. 2019. ↩ ↩²

7. U.S. Food and Drug Administration. How to Determine if Your Product is a Medical Device, accessed June 22, 2026. ↩

8. U.S. Food and Drug Administration. General Wellness: Policy for Low Risk Devices, final guidance, January 2026; accessed June 22, 2026. ↩

9. U.S. Department of Health and Human Services. Resources for Mobile Health Apps Developers, content last reviewed April 22, 2026; accessed June 22, 2026. ↩

10. Federal Trade Commission. Updated FTC Health Breach Notification Rule puts new provisions in place to protect users of health apps and devices, April 26, 2024; accessed June 22, 2026. ↩